CARYSIL
|
CARYSIL Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 19.58 | 24.26 | 14.66 | 8.27 | 6.65 |
CEPS(Rs) | 29.58 | 31.08 | 19.47 | 13.03 | 10.07 |
DPS(Rs) | 2.00 | 2.40 | 2.00 | 1.20 | 1.20 |
Book NAV/Share(Rs) | 112.35 | 93.65 | 71.70 | 59.12 | 51.20 |
Tax Rate(%) | 22.42 | 24.19 | 26.96 | 25.00 | 27.78 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 18.44 | 21.63 | 21.60 | 17.23 | 16.85 |
EBIT Margin(%) | 14.27 | 20.04 | 20.09 | 14.63 | 14.26 |
Pre Tax Margin(%) | 11.47 | 17.79 | 17.38 | 11.03 | 9.62 |
PAT Margin (%) | 8.90 | 13.49 | 12.69 | 8.28 | 6.95 |
Cash Profit Margin (%) | 13.33 | 17.15 | 16.78 | 12.59 | 10.38 |
Performance Ratios | |||||
ROA(%) | 8.35 | 13.82 | 10.99 | 7.43 | 6.35 |
ROE(%) | 19.18 | 29.57 | 22.52 | 15.73 | 13.92 |
ROCE(%) | 18.52 | 28.38 | 22.53 | 16.45 | 16.25 |
Asset Turnover(x) | 0.94 | 1.02 | 0.87 | 0.90 | 0.91 |
Sales/Fixed Asset(x) | 1.57 | 1.79 | 1.44 | 1.48 | 1.48 |
Working Capital/Sales(x) | 11.74 | 7.45 | 5.67 | 6.05 | 8.60 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.64 | 0.56 | 0.69 | 0.68 | 0.68 |
Receivable days | 62.51 | 69.17 | 85.61 | 77.03 | 74.33 |
Inventory Days | 72.15 | 59.88 | 67.35 | 74.95 | 73.89 |
Payable days | 104.74 | 131.01 | 110.49 | 93.97 | 115.17 |
Valuation Parameters | |||||
PER(x) | 27.75 | 34.25 | 21.14 | 6.77 | 16.68 |
PCE(x) | 18.37 | 26.73 | 15.91 | 4.29 | 11.02 |
Price/Book(x) | 4.84 | 8.87 | 4.32 | 0.95 | 2.17 |
Yield(%) | 0.37 | 0.29 | 0.65 | 2.14 | 1.08 |
EV/Net Sales(x) | 2.80 | 4.84 | 2.93 | 0.84 | 1.47 |
EV/Core EBITDA(x) | 14.99 | 20.43 | 12.12 | 4.43 | 8.32 |
EV/EBIT(x) | 19.65 | 24.17 | 14.59 | 5.73 | 10.33 |
EV/CE(x) | 2.34 | 4.24 | 2.32 | 0.71 | 1.28 |
M Cap / Sales | 2.45 | 4.58 | 2.67 | 0.54 | 1.14 |
Growth Ratio | |||||
Net Sales Growth(%) | 22.73 | 56.24 | 12.12 | 9.79 | 28.06 |
Core EBITDA Growth(%) | -3.16 | 53.18 | 43.10 | 17.56 | 40.85 |
EBIT Growth(%) | -12.64 | 55.87 | 53.99 | 12.63 | 46.67 |
PAT Growth(%) | -19.04 | 65.97 | 71.98 | 30.77 | 42.86 |
EPS Growth(%) | -19.29 | 65.53 | 77.23 | 24.39 | -71.13 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.73 | 0.55 | 0.53 | 0.65 | 0.73 |
Current Ratio(x) | 1.16 | 1.27 | 1.33 | 1.33 | 1.22 |
Quick Ratio(x) | 0.74 | 0.84 | 1.00 | 0.90 | 0.82 |
Interest Cover(x) | 5.09 | 8.88 | 7.41 | 4.07 | 3.07 |
Total Debt/Mcap(x) | 0.15 | 0.06 | 0.12 | 0.68 | 0.34 |
Compare Financial Ratios of peers of CARYSIL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CARYSIL | ₹2,458.9 Cr | -0.9% | -4.3% | 48.1% | Stock Analytics | |
HINDUSTAN UNILEVER | ₹554,574.0 Cr | -0.8% | 4.2% | -6.3% | Stock Analytics | |
GODREJ CONSUMER PRODUCTS | ₹136,869.0 Cr | 1.2% | 8.2% | 38.8% | Stock Analytics | |
DABUR INDIA | ₹97,497.6 Cr | -1.6% | 9.4% | 6.4% | Stock Analytics | |
COLGATEPALMOLIVE (INDIA) | ₹77,778.4 Cr | -0.1% | 9.1% | 76.9% | Stock Analytics | |
PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹51,024.5 Cr | -0.9% | -2.8% | 13.7% | Stock Analytics |
CARYSIL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CARYSIL | -0.9% |
-4.3% |
48.1% |
SENSEX | -1.5% |
-2.6% |
17.8% |
You may also like the below Video Courses